Dash 50mg Tablet

About

Dash 50mg Tablet contains Alendronate, a bisphosphonate medication primarily indicated for the treatment and prevention of osteoporosis. Its mechanism of action involves binding to bone mineral and inhibiting the activity of osteoclasts, the cells responsible for bone resorption. By reducing the rate of bone breakdown, Alendronate helps to preserve existing bone mass and can even increase bone density over time, thereby significantly lowering the risk of fragility fractures, particularly in the hip and spine. This medication is a cornerstone in the management of osteoporosis in postmenopausal women and men, as well as in other bone disorders like Paget's disease. Strict adherence to administration guidelines is crucial to maximize its therapeutic benefits and minimize potential gastrointestinal side effects, especially esophageal irritation.

Uses

• Treatment of postmenopausal osteoporosis
• Prevention of postmenopausal osteoporosis
• Treatment of osteoporosis in men
• Treatment of Paget's disease of bone

Directions For Use

Take with a full glass of plain water first thing in the morning, at least 30 minutes before food, drink, or other medications. Remain upright for at least 30 minutes.

Benefits

• Increases bone mineral density
• Reduces the risk of fractures (spine and hip)
• Prevents further bone loss
• Effective in postmenopausal osteoporosis
• Convenient once-weekly dosing for some formulations
• Improves overall bone strength

Side Effects

• Esophageal irritation or ulceration
• Abdominal pain
• Nausea
• Constipation
• Diarrhea
• Musculoskeletal pain
• Headache
• Dizziness
• Osteonecrosis of the jaw (rare)
• Atypical femur fractures (rare)
• Flu-like symptoms
• Rash

Safety Measures

• Alcohol - Limit alcohol intake as it can contribute to bone loss and may exacerbate gastrointestinal irritation, especially esophageal issues.
• Pregnancy - Generally not recommended during pregnancy due to limited data and potential for fetal harm. Consult your doctor.
• Breastfeeding - Not recommended during breastfeeding as it is unknown if alendronate is excreted in human milk; potential for adverse effects on the infant.
• Liver - No specific dosage adjustment is typically required for patients with liver impairment.
• Kidney - Contraindicated in severe renal impairment (creatinine clearance <35 mL/min). Use with caution in moderate impairment.
• Lung - No specific lung-related precautions, but ensure the patient can remain upright for at least 30 minutes after taking the dose to prevent esophageal irritation.

Disclaimer

MedEHub is committed to delivering reliable, expert-reviewd information to help consumers make informed health decisions. However, the content provided on this website is for informational purposes only and is not intended to replace professional medical advice, diagnosis or treatment.

Always consult your doctor for any medical concerns, and discuss your questions about health conditions or medications with a qualified healthcare professional. Do not ignore or delay seeking professional medical advice based on information found on Med E Hub.

Our goal is to complement, not replace, the essential doctor-patient relationship.